<ѻý>CPAP Turns in Mixed Results for Patients With Diabetic Eye Diseaseѻý> Slower progression of retinal disease, but an increase in microhemorrhages Oct 06, 2023
<ѻý>Smoking-Related Metabolic Changes Partly Drive Type 2 Diabetes Riskѻý> Those with the most metabolic changes, genetic risk had a threefold higher diabetes risk Oct 06, 2023
<ѻý>Faster-Acting Insulin Aspart Safe for Pregnant Women With Diabetesѻý> The faster formulation led to fewer hypoglycemia events versus conventional insulin aspart Oct 06, 2023
<ѻý>Mixed Bag for Early Metformin in Gestational Diabetesѻý> EMERGE trial misses on primary endpoint, but secondary outcomes suggest potential benefit Oct 03, 2023
<ѻý>Adding Tirzepatide to Basal Insulin Cuts HbA1c in Poorly Controlled T2Dѻý> Results with the GIP/GLP-1 receptor agonist were statistically superior to added insulin lispro Oct 03, 2023
<ѻý>Pharmacists Improve Diabetes Control for Hispanic Patientsѻý> Medication-adjustment recommendations were linked to some improvements in type 2 diabetes Oct 02, 2023
<ѻý>MedPod Today: Big Medical Bill; GLP-1 Agonist Plateau; Grateful Patient Fundraisingѻý> ѻý reporters offer further insights on these recently covered topics Sep 29, 2023 podcast
<ѻý>New Insight Into Hyperglycemia Risk With PI3K Inhibitor for Breast Cancerѻý> Significantly more common in community setting, predicted by high baseline HbA1c Sep 28, 2023
<ѻý>FDA Adds Intestinal Blockage Reports to Ozempic Labelingѻý> Joins other approved GLP-1 receptor agonists in noting the potential adverse reaction Sep 28, 2023
<ѻý>Postmenopausal Fracture Risk for SGLT2 Inhibitors Similar to Other Diabetes Drugsѻý> Lower risk compared with DPP-4 inhibitors, and similar risk versus GLP-1 receptor agonists Sep 26, 2023
<ѻý>Record-Breaking Obesity Certifications; 365-Day CGM Data; Med Spa Mounjaro Lawsuitsѻý> News and commentary from the endocrinology world Sep 26, 2023
<ѻý>AI System Outperforms Standard Review of Imaging for Retinal Diseaseѻý> Offers potential to reduce current manual grading workload Sep 25, 2023
<ѻý>The GLP-1 Agonist Plateau No One's Talking Aboutѻý> Weight stabilization is no surprise to specialists, but for patients it's more complicated Sep 22, 2023
<ѻý>FDA Approves Another SGLT2 Inhibitor for Treating CKDѻý> Empagliflozin adds indication in adults, regardless of diabetes status Sep 22, 2023
<ѻý>FDA Panel: All Thumbs Down for GLP-1 Agonist Implant for Diabetesѻý> We haven't seen "the best version of this device," said panel member Sep 22, 2023
<ѻý>Third Time's a Charm for GLP-1 Diabetes Device? FDA Staff Suggest Otherwise.ѻý> Advisory committee to weigh in on safety concerns with GLP-1 receptor agonist implant Sep 20, 2023
<ѻý>Diabetes in Night Owls; 'Paradigm-Shifting' Drugs; Transgender Trials Unethical?ѻý> News and commentary from the endocrinology world Sep 19, 2023
<ѻý>Direct-to-Consumer Lab Tests Raise Ethical Questions, Researchers Sayѻý> Privacy policies, terms of sale often are unclear Sep 18, 2023
<ѻý>Keto for Kids With Diabetes Carries Risk, AAP Warnsѻý> American Academy of Pediatrics outlines policy for low-, very low-carbohydrate diets Sep 18, 2023
<ѻý>Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enoughѻý> Also in TTHealthWatch: CVD death and obesity Sep 16, 2023 podcast
<ѻý>Mask Attack Leaves Actor Blind; Diabetes Risk in Night Owls; U.S. Blood Shortageѻý> Health news and commentary from around the Web gathered by ѻý staff Sep 12, 2023
<ѻý>When Temps Rise, So Do Medical Risks. Should Docs and Nurses Talk More About Heat?ѻý> "This is not your grandmother's heat," says policy expert Sep 10, 2023
<ѻý>Combo Anesthesia During Retinal Laser Treatment Reduced Pain Perceptionѻý> Topical and subconjunctival technique also reduced treatment interruptions Sep 08, 2023
<ѻý>New Weight-Loss Drugs Spark Debate About Safety During Surgeryѻý> Some anesthesiologists think current guidelines don't go far enough Sep 08, 2023
<ѻý>Endocrine Disruptors in Paper Straws; Wegovy's CV Benefit; Stroke and Infertility Txѻý> News and commentary from the endocrinology world Sep 05, 2023
<ѻý>Insulin Calculator Cleared; Twice-Rejected Diabetes Drug; Ozempic for Alcohol Use?ѻý> News and commentary from the endocrinology world Aug 29, 2023
<ѻý>Case Grows for SGLT2 Inhibitors as Gout Treatmentѻý> Large cohort study shows expansive benefits Aug 28, 2023
<ѻý>SGLT2 Inhibitors, Rapid Titration, IV Iron Get a Boost in New European HF Guidelineѻý> Other recommendations also released for endocarditis, cardiomyopathies, ACS, and more Aug 25, 2023
<ѻý>Liver Concerns Foil GLP-1 Drug; Not Enough Menopause Training; Wegovy Supply Limitsѻý> News and commentary from the endocrinology world Aug 15, 2023
<ѻý>Should People Without Diabetes Use Glucose Monitors?ѻý> Trend boosted by health buffs on social media, but benefit for healthy adults is unclear Aug 01, 2023
<ѻý>Kombucha Shows Potential Diabetes Benefit in Small Trialѻý> Diabetes patients saw glucose levels drop after drinking fermented tea Aug 01, 2023
<ѻý>Studies Examine Links Between Diabetes and Eye Disease, Treatment, Adverse Eventsѻý> Anti-VEGF therapy raises risk of systemic events; retinal effects of diabetes drugs differ Jul 31, 2023
<ѻý>Albuminuria Testing Falling Short in Patients at Risk for CKDѻý> If testing rates followed recommendations, some could start necessary meds sooner Jul 27, 2023
<ѻý>Aspartame Is a 'Possible' Carcinogen, WHO Declaresѻý> But the organization's recommended limits on aspartame consumption remain unchanged Jul 13, 2023
<ѻý>NAFLD and T2DM Bodes Higher Risk of Liver Decompensation, Cancerѻý> Several-fold higher risks compared with NAFLD patients without diabetes Jul 11, 2023
<ѻý>ASA: Hold GLP-1 Agonists Before Elective Surgeryѻý> Or else run the risk of aspirating under anesthesia due to delayed gastric emptying Jun 30, 2023
<ѻý>Diabetes Projected to Affect 1.3 Billion People by 2050ѻý> Advance of disease driven by high BMI, with social determinants of health playing a role Jun 28, 2023
<ѻý>Protocol Optimizing Meds for T2D and CVD Pushed Beyond Cardiology Aloneѻý> Endocrinologists urged to pay attention to COORDINATE trial Jun 27, 2023
<ѻý>Semaglutide Plus Cagrilintide Reduced Blood Sugar, Weight in T2Dѻý> Once-weekly CagriSema reduced body weight more than either agent alone Jun 27, 2023
<ѻý>High-Dose Semaglutide Pill Just as Effective as Wegovy for Weight Lossѻý> Another study showed two high doses were better at reducing HbA1c vs a 14-mg dose Jun 27, 2023